REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s products include the Fantom Encore and MOTIV bioresorbable vascular scaffolds for the treatment of coronary artery disease andbelow-the-knee peripheral artery disease, respectively. REVA is currently selling Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy and Turkey and is in the process of commercializing Fantom Encore in seven additional countries. REVA is based in San Diego, California.
![REVA Medical logo](https://files.capedge.com/8-K/0001564590-19-003162/gsxibo55mxli000001.jpg)
Company profile
Ticker
RVALL
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
SEC CIK
Corporate docs
IRS number
330810505
Latest filings (excl ownership)
15-12G
Securities registration termination
5 Mar 20
8-K
REVA Medical Successfully Completes Financial Restructuring
5 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 20
Latest ownership filings
SC 13G/A
JPMORGAN CHASE & CO
8 Jan 21
SC 13G/A
Beneficial ownership report (amended)
31 Jan 20
4
Robert Bernard Stockman
14 Nov 19
4
BRIAN H DOVEY
13 Nov 19
SC 13G/A
REVA Medical, Inc.
4 Apr 19
4
SACHS INTERNATIONAL GOLDMAN
4 Apr 19
SC 13G/A
REVA Medical, Inc.
14 Feb 19
5
Nicholas Taylor
14 Feb 19
SC 13G
REVA Medical, Inc.
14 Feb 19
3
Leigh Elkolli
14 Jan 19
Institutional ownership, Q1 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|